<DOC>
	<DOCNO>NCT03088644</DOCNO>
	<brief_summary>The primary purpose study measure whole body distribution radiation dosimetry 18F-JNJ-64413739 ( Part A ) , measure uptake , distribution , clearance ( CL ) 18F-JNJ-64413739 brain healthy male subject Positron Emission Tomography ( PET ) model tissue specific kinetics 18F-JNJ-64413739 appropriate input function ( IF ) ( Part B ) , measure subject test retest variability distribution 18F-JNJ-64413739 brain healthy male subject compare PET scan obtain least 1 week apart ( Part C ) follow single oral dose administration JNJ-54175446 , measure block 18F-JNJ-64413739 uptake brain time reach maximum plasma concentration ( tmax ) JNJ-54175446 model exposure/receptor interaction JNJ-54175446 healthy male subject ( Part D ) .</brief_summary>
	<brief_title>A Study Investigate P2X7 Receptor Occupancy JNJ-54175446 With Newly Developed P2X7 Receptor Positron Emission Tomography ( PET ) Tracer 18F-JNJ-64413739</brief_title>
	<detailed_description />
	<criteria>Body mass index ( BMI ) 18 30 kilogram per square meter ( kg/m^2 ) inclusive ( BMI = weight/height^2 ) Nonsmoker ( smoke 3 month prior screen ) Is willing allow investigator place arterial catheter radial artery , assess via physical examination ( Allen Test ) good subject arterial catheter placement allergic local anesthetic catheter placement ( Part BCD ) During study minimum 1 spermatogenesis cycle ( define approximately 90 day ) receive last dose study drug , addition highly effective method contraception , man : sexually active woman childbearing potential vasectomy must agree use barrier method contraception ( e.g. , condom spermicidal foam/gel/film/cream/suppository partner occlusive cap ( diaphragm cervical/vault cap ) spermicidal foam/gel/film/cream/suppository ) . In addition , female partner also use highly effective method birth control ( e.g . hormonal contraception ) least duration ; sexually active woman pregnant must use condom ; must agree donate sperm Subjects must sign informed consent document indicate understand purpose , procedure require study willing participate study comply study procedure restriction Exposed great ( &gt; ) 1 millisievert ( mSv ) ionize radiation participate subject research study 12 month start study Clinically significant abnormal physical neurological examination , vital sign 12lead electrocardiogram ( ECG ) screen admission History current significant medical illness include ( limited ) cardiac arrhythmia cardiac disease , hematological disease , lipid abnormality , bronchospastic respiratory disease , diabetes mellitus , renal hepatic insufficiency , thyroid disease , parkinson 's disease , infection , illness Investigator considers exclude subject . History epilepsy fit unexplained blackout Serology positive hepatitis B surface antigen ( HBsAg ) , hepatitis C virus ( HCV ) antibodies human immunodeficiency virus ( HIV ) antibody Subject history drug alcohol abuse accord Diagnostic Statistical Manual Mental Disorders ( 5th edition ) ( DSMV ) criterion within 6 month Screening positive test result ( ) alcohol and/or drug abuse ( opiate ( include methadone ) , cocaine , amphetamine , methamphetamine , cannabinoids , barbiturate , ecstasy benzodiazepine ) screen admission period</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>